Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Doxorubicin

An anthracycline antitumour antibiotic obtained in Italy in 1969 from a mutant strain of the bacterium Streptomyces peucetius: it is one of the most widely used chemotherapy drugs, against breast cancer, lymphomas, leukaemias and sarcomas. This family brings together the active ingredient, pharmacopoeial impurities and other impurities.

Did you know?The original strain of the bacterium was found in a soil sample collected near Castel del Monte, in Apulia: it produced a red pigment, and the medicine itself is a deep red.

DoxorubicinGo to the active ingredient →
DoxorubicinActive ingredientDoxorubicinCat. No. P-D184-001CAS 23214-92-8

EDQM standards 1

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.